Small Caps with High Revenue Growth
Small cap stocks under $2B market cap growing revenue faster than 25% annually — these are the early-stage compounders where the biggest multi-baggers are born.
| Ticker | Company | Price | Rev. Growth | Mkt Cap | Net Margin | Sector |
|---|---|---|---|---|---|---|
| UROY | Uranium Royalty Corp | $3.69 +0% | 416400% | $540.5M | 8% | Energy |
| SPWR | SunPower Corporation | $1.25 -2.34% | 1164.5% | $149.4M | 5.1% | Technology |
| RXRX | Recursion Pharmaceuticals | $3.11 +1.63% | 681.7% | $1.64B | 0% | Healthcare |
| VXRT | Vaxart | $0.61 +0% | 586.5% | $147.3M | 6.9% | Healthcare |
| ANAB | AnaptysBio | $57.68 +1.67% | 151.1% | $1.66B | -5.6% | Healthcare |
| TIP.MI | Tamburi Investment Partners | $7.94 -1.24% | 139.4% | $1.29B | 2659.2% | Financial Services |
| HYPR | Hyperfine | $1.13 +3.67% | 128% | $110.7M | -262.3% | Healthcare |
| MNTS | Momentus Space | $3.28 -12.06% | 118.7% | $5.5M | 0% | Industrials |
| CCCC | C4 Therapeutics | $2.82 +4.44% | 112.8% | $275.2M | -292.1% | Healthcare |
| LAND | Gladstone Land | $10.34 +0.78% | 96.5% | $431.2M | 15.3% | Real Estate |
| EKT.DE | Energiekontor | $35.35 -2.48% | 89.7% | $493.4M | 24.4% | Utilities |
| CRBU | Caribou Biosciences | $1.94 -2.51% | 89.7% | $187.5M | 0% | Healthcare |
| EVGO | EVgo | $1.71 -3.39% | 75.5% | $535.4M | -10.8% | Consumer Cyclical |
| NVAX | Novavax | $7.70 -3.99% | 66.6% | $1.25B | 39.2% | Healthcare |
| WKHS | Workhorse Group | $2.65 -4.68% | 63.7% | $23.3M | 0% | Consumer Cyclical |
| FCEL | FuelCell Energy | $6.60 +2.17% | 60.7% | $349.7M | -107.5% | Industrials |
| RDW | Redwire Corporation | $9.73 +7.16% | 56.4% | $1.87B | -67.6% | Industrials |
| MOL.MI | Mutuionline | $31.35 -0.63% | 55.6% | $1.18B | 4.1% | Financial Services |
| USAS | Americas Gold and Silver | $5.52 -1.25% | 54.9% | $1.77B | -74.2% | Basic Materials |
| CTM.ST | Catena Media | $2.18 -3.96% | 53.2% | $164.9M | -16.1% | Communication Services |
| FAE.MC | Faes Farma | $4.70 -0.95% | 47.7% | $1.46B | 12.7% | Healthcare |
| REMEDY.HE | Remedy Entertainment | $12.12 +1.17% | 46.3% | $164.7M | -21.9% | Communication Services |
| MNKD | MannKind Corporation | $2.50 -1.57% | 45.8% | $770.3M | 1.7% | Healthcare |
| CTSO | Cytosorbents Corporation | $0.58 +6.52% | 41.6% | $36.6M | -22.1% | Healthcare |
| PRLD | Prelude Therapeutics | $3.46 +0.29% | 41% | $217.5M | 0% | Healthcare |
| TTGT | TechTarget | $4.12 +6.46% | 40.1% | $297.8M | -207.1% | Technology |
| BLDP | Ballard Power Systems | $2.48 +2.9% | 37.2% | $746.3M | -91.5% | Industrials |
| ALKT | Alkami Technology | $16.56 +3.44% | 34.7% | $1.76B | -10.7% | Technology |
| FLYW | Flywire Corporation | $11.78 +1.73% | 34% | $1.44B | 2.2% | Technology |
| SIP.BR | Sipef | $97.80 +0.41% | 33.7% | $1.02B | 22% | Consumer Defensive |
| 2GB.DE | 2G Energy | $40.00 +3.49% | 29.8% | $717.6M | 5.9% | Industrials |
| CODA | Coda Octopus Group | $11.89 +2.32% | 28.8% | $134.1M | 14.8% | Industrials |
Analysis and Context
This screener identifies 32 growth stocks meeting our growth criteria — updated daily. The average revenue growth rate of listed companies is 13147.1% annually. Growth companies are heavily concentrated in Healthcare (11 companies). High revenue growth alone doesn't make a great investment — the path to profitability and quality of growth (organic vs. acquisition-driven) are equally critical. The median net margin of companies in this list is 60.4%. Analysts see an average of 131.7% upside in these growth names. Growth stocks are particularly sensitive to interest rate changes — rising rates increase the discount rate and reduce the present value of future earnings. Use this list as a starting point for deeper research into unit economics, customer retention, and total addressable market.
Ready to invest?
Compare the best brokers for US and European stocks — fees, platforms and account types side by side.
Compare brokers →